GlennWWortmannMDFIDSA, FACP
Infectious Disease • Washington, DCProfessor of Clinical Medicine, Georgetown University School of Medicine
Dr. Wortmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Irving St Nw
Suite 2a38b
Washington, DC 20010Phone+1 202-877-7164
Education & Training
National Capital ConsortiumFellowship, Infectious Disease, 1995 - 1998- National Capital ConsortiumResidency, Internal Medicine, 1992 - 1994
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1988 - 1989
Virginia Commonwealth University School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 1989 - 2026
MD State Medical License 2012 - 2025
DC State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Start of enrollment: 2004 Oct 01
- Sodium Stibogluconate Treatment of Leishmaniasis Start of enrollment: 2002 Jun 01
- Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 Start of enrollment: 2020 Oct 09
- Join now to see all
Publications & Presentations
PubMed
- Building Clinical Care Capacity for Patients With Special Pathogens in Advance of the Next Outbreak.Lauren Wiesner, Jade Flinn, Brooke Brewer, Aaron Resnick, Sharon Vanairsdale Carrasco
Health Security. 2024-09-01 - Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco
Frontiers in Immunology. 2024-01-01 - 4 citationsIntravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.Samuel M Brown, Christina E Barkauskas, Birgit Grund, Shweta Sharma, Andrew N Phillips
The Lancet. Respiratory Medicine. 2023-09-01
Press Mentions
Doctors Warn of Possible Triple Virus Threat This WinterOctober 25th, 2022- Don’t Want the Pfizer or Moderna Shot? Now You Can Get a Novavax BoosterOctober 25th, 2022
- No, It's Not 'Too Early' for the Flu ShotSeptember 16th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
